Impact of atrial fibrillation on mortality, stroke, and medical costs.
about
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationRisk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillationIncreased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air pollution.Shensongyangxin Capsules for Paroxysmal Atrial Fibrillation: A Systematic Review of Randomized Clinical TrialsAtrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studiesOptimising stroke prevention in non-valvular atrial fibrillationPhotoacoustic Characterization of Radiofrequency Ablation LesionsWall-motion based analysis of global and regional left atrial mechanics.In vitro photoacoustic visualization of myocardial ablation lesions.The golden age of minimally invasive cardiothoracic surgery: current and future perspectives.A review of carvedilol arrhythmia data in clinical trials.Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation.A systems biology strategy on differential gene expression data discloses some biological features of atrial fibrillation.Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.Therapy of atrial fibrillation: rhythm control versus rate control.Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score.Risk of thromboembolism in acute atrial fibrillation or atrial flutter.Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study.Trends in catheter ablation for atrial fibrillation in the United States.Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry.Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.A comprehensive view of sex-specific issues related to cardiovascular disease.Meta-analysis of effect of vernakalant on conversion of atrial fibrillation.Reduced incidence of cardiac arrhythmias in walkers and runners.Challenges in the classification of atrial fibrillation.Physical activity and the risk of incident atrial fibrillation in women.Epicardial adipose tissue thickness and ablation outcome of atrial fibrillationRelationship of CHA2DS2-VASc and CHADS2 score to left atrial remodeling detected by velocity vector imaging in patients with atrial fibrillationTemporal trends in stroke admissions in Denmark 1997-2009.Improving ablation strategies for the treatment of atrial fibrillation.Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study.Hybrid therapy in the management of atrial fibrillation.Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) studyRelations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UKAge and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial FibrillationStroke Prevention in Atrial Fibrillation: Where are We Now?Cost considerations in the management of atrial fibrillation - impact of dronedarone.
P2860
Q24234691-A2AE5833-C329-48EF-80C0-2275182A1032Q24804548-779649D0-E147-4ED0-B615-11A6F93CE325Q25256818-D1E95D87-8D6E-43A1-ADED-21D4B348879CQ26753062-B299F1C0-7727-44E5-881E-F3B8CBAE4FE8Q26770901-686CE50E-4C8D-43F7-A237-E1C62DDB07CDQ28200609-A4464B04-BE70-4A43-9764-963FB884F9E5Q30403294-AB1F3420-5391-46E8-AEB6-FCB3CEBF8DECQ30405273-7733B23B-B356-4593-AB23-C1FF712DD6F7Q30421753-44233A03-FEF6-4619-BDDF-B98BD5EBC50DQ30469960-AEA6487C-6509-4A1A-9931-129D355B57B7Q30992419-D754EFC0-7EA0-408C-A7A9-4CD0EFDF2A42Q33723616-10C33BAA-F03F-4372-83DC-B8EC3154D103Q33741972-5A14ED33-E136-4309-B97D-5513434B14A9Q33815844-3D1CB196-B606-449D-B680-48311B828575Q33931009-3135FB7D-E673-46D7-B806-24C30557640FQ33940481-9F16CE78-90EF-47D5-8879-E8CF61EDE0D1Q33984012-09FE987B-4DC5-4CD1-8C84-90A1187A8416Q34026450-22C95284-A711-41E9-A1BC-13C3A4FC66EBQ34038150-D05AE67B-2496-4468-BA32-07A10DBE3650Q34056331-A9A9D01E-99B9-4EDD-9C27-B132FE7FF62AQ34091490-D2399272-8F31-4DB6-923C-C35C9EB66623Q34512403-ADDCBE85-8FD4-438C-BF3F-9ED552C4653AQ34577461-81056919-346D-4AF6-82DF-AA8B739A1758Q34623706-819BF77F-16C0-4417-8B0B-E1557132FC57Q34769792-FD1D73AA-83CB-4279-96C1-0D5E74D94FBBQ34774724-77606347-F406-4F95-BF31-9677AC5D3C05Q34990379-E4672405-1CBF-4F5E-BF0D-3DC36DEA8A34Q34997418-7082AB6C-B310-4541-B28B-67DFDF6BFE14Q35023297-9BB7A20D-9763-4BBE-B024-32C5A1AF8226Q35028738-4ACC7806-48E0-49D2-BB1A-44BCB2AC4E49Q35059670-742F8788-A2C9-4A61-8B32-00F73AE57353Q35062021-B23E02D5-5C0D-49EC-94E6-A469DAD29E7DQ35098286-19B926A6-60F7-4C2E-A9B1-5BD929AAAB1EQ35168786-9FE4A0F4-8865-48BB-A1DD-670BE23E3D9EQ35257273-77E197B7-024E-4D07-9C9A-B2BB0ECAC54AQ35575045-21C9695B-E86E-43D3-8E40-7B6023CDEC74Q35582163-E2CE5357-3F2B-4410-B29C-0C0BD10EED82Q35764897-ABBA722B-5F73-417E-8783-6F3E4CEBE5EDQ35811581-644701EB-DCFD-4DB7-967C-06614A958A1DQ35832134-BFFA94AC-E85B-4A42-B4AE-490E15383B73
P2860
Impact of atrial fibrillation on mortality, stroke, and medical costs.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Impact of atrial fibrillation on mortality, stroke, and medical costs.
@en
Impact of atrial fibrillation on mortality, stroke, and medical costs.
@nl
type
label
Impact of atrial fibrillation on mortality, stroke, and medical costs.
@en
Impact of atrial fibrillation on mortality, stroke, and medical costs.
@nl
prefLabel
Impact of atrial fibrillation on mortality, stroke, and medical costs.
@en
Impact of atrial fibrillation on mortality, stroke, and medical costs.
@nl
P2093
P1476
Impact of atrial fibrillation on mortality, stroke, and medical costs.
@en
P2093
P304
P356
10.1001/ARCHINTE.158.3.229
P407
P577
1998-02-01T00:00:00Z